The API Innovation Center (APIIC) today released an industry white paper detailing the United States’ overreliance on foreign production of essential medicines and presenting a comprehensive plan to ...

For much of her early career, Shobie Ramakrishnan called Silicon Valley home. GSK’s chief digital and technology officer ...

The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...

For some Big Pharma companies, sales in China contributed to more than 10 percent of global sales, making China a top market ...

The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...

Pharma’s reliance on global supply chains and its need for vast quantities of water make it particularly vulnerable to climate change. But preparing to adapt to the phenomenon presents an ...

Drug shortages are generally not a common occurrence across the pharmaceutical industry. Considering the complexity of the supply chains involved, the manufacturing expertise required, and the ...

The trial results are critical, as it brings Eli Lilly’s pill one step closer to becoming a new, needle-free alternative for ...

On April 2, 2025, the United States will undergo a significant shift in trade policy under President Donald Trump. Dubbed the ...

Learn what kinds of supply chain flows to monitor, common hurdles to overcome, and how experts like ShipBob can help.